Total Payments
$944.51
2024 Payments
$229.23
Companies
20
Transactions
49
Medicare Patients
5,283
Medicare Billing
$465,532
Payment Breakdown by Category
Food & Beverage$850.51 (90.0%)
Education$94.00 (10.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $850.51 | 48 | 90.0% |
| Education | $94.00 | 1 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $168.89 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $113.25 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $93.00 | 7 | $0 (2024) |
| PFIZER INC. | $75.82 | 4 | $0 (2024) |
| Novo Nordisk Inc | $65.80 | 4 | $0 (2024) |
| Exact Sciences Corporation | $62.09 | 2 | $0 (2023) |
| Lilly USA, LLC | $55.70 | 3 | $0 (2022) |
| Amarin Pharma Inc. | $40.77 | 2 | $0 (2022) |
| Dexcom, Inc. | $39.50 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $30.77 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $229.23 | 13 | Bayer Healthcare Pharmaceuticals Inc. ($62.41) |
| 2023 | $379.44 | 16 | Astellas Pharma US Inc ($94.00) |
| 2022 | $112.48 | 7 | AstraZeneca Pharmaceuticals LP ($38.62) |
| 2021 | $223.36 | 13 | PFIZER INC. ($59.38) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.24 | General |
| 12/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Gastroenterology | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Gastroenterology | ||||||
| 07/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardio-renal | ||||||
| 06/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardio-renal | ||||||
| 05/03/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/15/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardio-renal | ||||||
| 03/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Biological | ||||||
| 02/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Cardio-renal | ||||||
| 12/05/2023 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Genetic Disease | ||||||
| 11/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardio-renal | ||||||
| 11/20/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Endocrinology | ||||||
| 11/07/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Oral Contraceptive | ||||||
| 10/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardio-renal | ||||||
| 10/04/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Endocrinology | ||||||
| 09/28/2023 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $11.00 | General |
| Category: GERD | ||||||
| 08/16/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Oncology | ||||||
| 07/17/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| Category: Insulin Pump | ||||||
| 07/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardio-renal | ||||||
| 06/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $36.44 | General |
| Category: Oncology | ||||||
| 06/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,286 | 2,512 | $255,189 | $105,984 |
| 2022 | 14 | 1,392 | 2,875 | $282,300 | $116,160 |
| 2021 | 14 | 1,379 | 3,294 | $308,144 | $134,644 |
| 2020 | 13 | 1,226 | 2,814 | $267,656 | $108,743 |
Total Patients
5,283
Total Services
11,495
Medicare Billing
$465,532
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 634 | $115,071 | $47,428 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 231 | $47,517 | $23,422 | 49.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 165 | 165 | $28,133 | $17,495 | 62.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 168 | 169 | $33,462 | $8,214 | 24.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 172 | 172 | $6,054 | $2,599 | 42.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 169 | 169 | $5,949 | $2,554 | 42.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 13 | 60 | $4,950 | $1,840 | 37.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 176 | 193 | $8,567 | $1,578 | 18.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 74 | $3,134 | $647.50 | 20.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 36 | 213 | $1,704 | $168.07 | 9.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 36 | 432 | $648.00 | $39.01 | 6.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 145 | 380 | $78,166 | $39,456 | 50.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 181 | 533 | $96,740 | $36,510 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 165 | 165 | $28,133 | $17,864 | 63.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 166 | 170 | $33,660 | $8,221 | 24.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 16 | 107 | $8,828 | $3,425 | 38.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 177 | 177 | $6,230 | $2,730 | 43.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 173 | 173 | $6,090 | $2,620 | 43.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 170 | 188 | $8,345 | $1,532 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 22 | $2,576 | $1,017 | 39.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 16 | 38 | $3,344 | $963.03 | 28.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 13 | 22 | $3,727 | $859.33 | 23.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 53 | 83 | $3,515 | $699.00 | 19.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 48 | 265 | $2,120 | $216.69 | 10.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 49 | 552 | $828.00 | $46.35 | 5.6% |
About Amanda Bennett, FNP-C
Amanda Bennett, FNP-C is a Family healthcare provider based in Willcox, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558329862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Bennett, FNP-C has received a total of $944.51 in payments from pharmaceutical and medical device companies, with $229.23 received in 2024. These payments were reported across 49 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($850.51).
As a Medicare-enrolled provider, Bennett has provided services to 5,283 Medicare beneficiaries, totaling 11,495 services with total Medicare billing of $465,532. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Willcox, AZ
- Active Since 05/03/2006
- Last Updated 10/17/2011
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1558329862
Products in Payments
- Kerendia (Drug) $168.89
- Cologuard Collection Kit (Device) $62.09
- Ozempic (Drug) $41.76
- FARXIGA (Drug) $41.14
- COLOGUARD DNA CAPTURE REAGENTS (Device) $41.09
- Vascepa (Drug) $40.77
- Dexcom G6 Transmitter (Medical Supply) $39.50
- TRULICITY (Drug) $36.29
- XIFAXAN (Drug) $28.79
- TZIELD (Biological) $28.54
- GIVLAARI (Drug) $27.90
- Rybelsus (Drug) $24.04
- VRAYLAR (Drug) $22.68
- VOQUEZNA (Drug) $20.49
- MOUNJARO (Drug) $19.41
- Veozah (Drug) $19.25
- PREMARIN (Drug) $18.29
- ENTRESTO (Drug) $17.31
- SLYND (Drug) $17.14
- PREVNAR 20 (Biological) $16.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.